c-Rel is essential for B lymphocyte survival and cell cycle progression. 1998

J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
Graduate School of Medical Sciences, Weill Medical College of Cornell University, New York, NY 10021, USA.

c-Rel is a lymphoid-specific member of the NF-kappaB/Rel family of transcriptional factors. To investigate the role of c-Rel in B lymphocyte function, we generated a c-Rel(-/-) mouse via a gene targeting approach. Although early lymphocyte development is normal in c-Rel(-/-) mice, there are significantly fewer B cells displaying a memory (IgM/IgD-) phenotype. Upon immunization, c-Rel(-/-) mice generate fewer B cells with a germinal center (PNAhi) phenotype. In vitro, c-Rel(-/-) B cells proliferate poorly upon ligation of their surface IgM or CD40 receptors or when stimulated with either lipopolysaccharide (LPS) or T cell help. Early molecular events that precede proliferation, such as increases in RNA synthesis as well as IL-2 receptor alpha chain expression, are greatly diminished in c-Rel(-/-) B cells. Furthermore, c-Rel(-/-) B cells are impaired in the ability to receive survival signals generated by anti-IgM or LPS. In contrast, CD40-mediated cell survival is normal in c-Rel(-/-) B cells, suggesting the involvement of a survival-signaling pathway that is independent of c-Rel. When c-Rel (-/-) B cells are co-stimulated with either anti-IgM and CD40 or LPS and CD40, they are rendered capable of progressing through the cell cycle. Finally, co-culture experiments suggest that the defects observed in c-Rel(-/-) B cells are intrinsic to the cell and can not be rescued through either cell-cell contact or addition of soluble factors. Thus, c-Rel is requisite for differentiation to the germinal center and memory B cells in vivo and is required for the transduction of survival and cell cycle progression signals mediated by anti-IgM and LPS in vitro. Furthermore, while c-Rel is involved in CD40-induced proliferation, it is apparently dispensable for the survival signals transduced by CD40.

UI MeSH Term Description Entries
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D020569 Proto-Oncogene Proteins c-rel Cellular DNA-binding proteins encoded by the rel gene (GENES, REL). They are expressed predominately in hematopoietic cells and may play a role in lymphocyte differentiation. Rel frequently combines with other related proteins (NF-KAPPA B, I-kappa B, relA) to form heterodimers that regulate transcription. Rearrangement or overexpression of c-rel can cause tumorigenesis. c-rel Proteins,p68(c-rel),rel Proto-Oncogene Proteins,Proto-Oncogene Products c-rel,Proto-Oncogene Protein c-rel,Proto-Oncogene Proteins rel,c-rel Protein,p68 c-rel,rel Proto-Oncogene Product p68,Protein, c-rel,Proteins, c-rel,Proto Oncogene Products c rel,Proto Oncogene Protein c rel,Proto Oncogene Proteins c rel,Proto Oncogene Proteins rel,Proto-Oncogene Proteins, rel,c rel Protein,c rel Proteins,c-rel, Proto-Oncogene Products,c-rel, Proto-Oncogene Protein,c-rel, Proto-Oncogene Proteins,c-rel, p68,p68 c rel,rel Proto Oncogene Product p68,rel Proto Oncogene Proteins

Related Publications

J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
October 2001, Immunity,
J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
November 2003, Oncogene,
J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
February 2014, The Journal of investigative dermatology,
J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
June 1997, Oncogene,
J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
April 2019, Nature,
J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
September 1999, Cellular immunology,
J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
March 1999, International immunology,
J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
March 2021, Cellular & molecular immunology,
J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
August 2002, International immunology,
J R Tumang, and A Owyang, and S Andjelic, and Z Jin, and R R Hardy, and M L Liou, and H C Liou
February 2019, Experimental dermatology,
Copied contents to your clipboard!